Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-026912
Filing Date
2017-05-12
Accepted
2017-05-12 16:24:16
Documents
48
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v465938_10q.htm 10-Q 331646
2 EXHIBIT 31.1 v465938_ex31-1.htm EX-31.1 9554
3 EXHIBIT 31.2 v465938_ex31-2.htm EX-31.2 9210
4 EXHIBIT 32.1 v465938_ex32-1.htm EX-32.1 4959
5 EXHIBIT 99.1 v465938_ex99-1.htm EX-99.1 42818
12 GRAPHIC logo_ex99-1.jpg GRAPHIC 6866
  Complete submission text file 0001144204-17-026912.txt   2462420

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT fencf-20170331.xml EX-101.INS 493217
7 XBRL TAXONOMY EXTENSION SCHEMA fencf-20170331.xsd EX-101.SCH 32666
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fencf-20170331_cal.xml EX-101.CAL 19326
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fencf-20170331_def.xml EX-101.DEF 162677
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20170331_lab.xml EX-101.LAB 205711
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20170331_pre.xml EX-101.PRE 182265
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32295 | Film No.: 17838990
SIC: 2836 Biological Products, (No Diagnostic Substances)